| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000029074 |
| Receipt No. | R000033255 |
| Scientific Title | The mortality of chronic liver diseases including viral hepatitis and non alcoholic liver disease in Kyoto north area |
| Date of disclosure of the study information | 2017/12/01 |
| Last modified on | 2021/03/23 (Ver. 4) |
| Basic information | ||
| Public title | The mortality of chronic liver diseases including viral hepatitis and non alcoholic liver disease in Kyoto north area | |
| Acronym | The mortality of chronic liver disease | |
| Scientific Title | The mortality of chronic liver diseases including viral hepatitis and non alcoholic liver disease in Kyoto north area | |
| Scientific Title:Acronym | The mortality of chronic liver disease | |
| Region |
|
|
| Condition | ||
| Condition | Chronic liver disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The aim of this study is to find out the prevalence and the risk of HCC, liver failure, the event of cardiovascular events in the patients with chronic liver disease. |
| Basic objectives2 | Others |
| Basic objectives -Others | The aims is to assess the mortality of chronic liver diseases. |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | The prevalence of the liver disease related events; HCC, esophagus varices, liver failure. and the cardiovascular events during 10 years observation period. |
| Key secondary outcomes | Overall survival, the direct cause of death, the rate of haepato-carcinogenesis, the rate of SVR and reccurance of HCV, the stage of liver fibrosis, the IHC of LOX-1, aSMA, TGFb in the liver tissues, the concentration of serum sLOX-1. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Chronic liver disease patients going to North Medical Center of Kyoto prefectural university of medicine. | |||
| Key exclusion criteria | No exclusion criteria | |||
| Target sample size | 350 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kyoto prefectural university of medicine | ||||||
| Division name | Gastroenterology | ||||||
| Zip code | 602-8566 | ||||||
| Address | Kamigyoku kawaramatichitori hirokojiagaru kajiicho 465, Kyoto, Japan | ||||||
| TEL | 0752515519 | ||||||
| chiroinu@koto.kpu-m.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kyoto prefectural university of medicine | ||||||
| Division name | Gastroenterology | ||||||
| Zip code | 602-8566 | ||||||
| Address | Kamigyoku kawaramatichitori hirokojiagaru kajiicho 465, Kyoto, Japan | ||||||
| TEL | 0752515519 | ||||||
| Homepage URL | |||||||
| chiroinu@koto.kpu-m.ac.jp | |||||||
| Sponsor | |
| Institute | Kyoto prefectural university of medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kyoto prefectural university of medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Local Government |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kyoto prefectural university of medicine IRB |
| Address | Kamigyoku kawaramatichitori hirokojiagaru kajiicho 465, Kyoto, Japan |
| Tel | 0752515519 |
| rinri@koto.kpu-m.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | under trial |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000033255 |